 Fan Zhang
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 19 | 2026 | 1180 | 3.020 |
Why?
| | Single-Cell Analysis | 13 | 2025 | 362 | 2.780 |
Why?
| | Synovial Membrane | 10 | 2026 | 123 | 1.810 |
Why?
| | Computational Biology | 7 | 2025 | 669 | 1.540 |
Why?
| | Transcriptome | 7 | 2025 | 1038 | 1.460 |
Why?
| | Gene Expression Profiling | 4 | 2025 | 1767 | 1.320 |
Why?
| | B-Lymphocytes | 6 | 2025 | 870 | 1.160 |
Why?
| | Machine Learning | 3 | 2025 | 587 | 0.870 |
Why?
| | Th17 Cells | 2 | 2025 | 101 | 0.870 |
Why?
| | Algorithms | 7 | 2025 | 1845 | 0.850 |
Why?
| | Immunophenotyping | 2 | 2025 | 319 | 0.840 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 530 | 0.720 |
Why?
| | Macrophages | 4 | 2026 | 1507 | 0.710 |
Why?
| | Lymphocyte Activation | 2 | 2025 | 1132 | 0.700 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2025 | 919 | 0.690 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2025 | 1140 | 0.680 |
Why?
| | Fibroblasts | 9 | 2026 | 1025 | 0.640 |
Why?
| | Cytokines | 5 | 2023 | 2067 | 0.630 |
Why?
| | Genome-Wide Association Study | 3 | 2026 | 1407 | 0.600 |
Why?
| | Anti-Citrullinated Protein Antibodies | 3 | 2026 | 127 | 0.600 |
Why?
| | Sequence Analysis, DNA | 2 | 2017 | 777 | 0.490 |
Why?
| | Inflammation | 8 | 2025 | 2878 | 0.450 |
Why?
| | Sequence Analysis, RNA | 3 | 2024 | 442 | 0.450 |
Why?
| | Models, Theoretical | 1 | 2017 | 558 | 0.390 |
Why?
| | Phenotype | 5 | 2026 | 3155 | 0.390 |
Why?
| | Colitis, Ulcerative | 3 | 2024 | 148 | 0.380 |
Why?
| | Software | 3 | 2025 | 680 | 0.340 |
Why?
| | Humans | 33 | 2026 | 145474 | 0.290 |
Why?
| | Neoplasms | 2 | 2021 | 2906 | 0.270 |
Why?
| | Granzymes | 2 | 2025 | 49 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 3 | 2026 | 2378 | 0.260 |
Why?
| | Gene Expression | 3 | 2024 | 1476 | 0.250 |
Why?
| | Osteopontin | 1 | 2026 | 35 | 0.240 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1996 | 0.240 |
Why?
| | Cluster Analysis | 2 | 2025 | 500 | 0.240 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 664 | 0.240 |
Why?
| | Protein Interaction Maps | 1 | 2026 | 51 | 0.230 |
Why?
| | Fibrin | 1 | 2026 | 84 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2024 | 2158 | 0.220 |
Why?
| | Adalimumab | 1 | 2024 | 55 | 0.210 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.200 |
Why?
| | Receptors, Glucocorticoid | 1 | 2024 | 129 | 0.190 |
Why?
| | Adipocytes | 1 | 2024 | 223 | 0.190 |
Why?
| | Microglia | 1 | 2025 | 270 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2024 | 298 | 0.180 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 273 | 0.180 |
Why?
| | Complement Activation | 1 | 2025 | 399 | 0.170 |
Why?
| | Complement System Proteins | 1 | 2025 | 314 | 0.170 |
Why?
| | Quantitative Trait Loci | 1 | 2023 | 378 | 0.170 |
Why?
| | Crohn Disease | 2 | 2024 | 260 | 0.170 |
Why?
| | Genomics | 3 | 2026 | 825 | 0.170 |
Why?
| | Receptors, IgG | 1 | 2021 | 77 | 0.170 |
Why?
| | Flow Cytometry | 3 | 2020 | 1162 | 0.170 |
Why?
| | Antirheumatic Agents | 1 | 2024 | 307 | 0.170 |
Why?
| | Immunity, Innate | 2 | 2024 | 835 | 0.160 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1321 | 0.160 |
Why?
| | Leukocytes | 2 | 2019 | 296 | 0.160 |
Why?
| | Signal Transduction | 3 | 2024 | 5216 | 0.160 |
Why?
| | Glucocorticoids | 1 | 2024 | 531 | 0.160 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 280 | 0.160 |
Why?
| | Chromatin | 1 | 2024 | 553 | 0.150 |
Why?
| | Transcription Factors | 2 | 2025 | 1734 | 0.150 |
Why?
| | Organ Specificity | 1 | 2020 | 309 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 271 | 0.150 |
Why?
| | Neoplasm Grading | 1 | 2020 | 310 | 0.150 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2019 | 16 | 0.150 |
Why?
| | Genome | 1 | 2021 | 305 | 0.150 |
Why?
| | Lupus Nephritis | 1 | 2019 | 67 | 0.140 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2021 | 238 | 0.140 |
Why?
| | Gene Frequency | 2 | 2017 | 487 | 0.140 |
Why?
| | Cell Communication | 1 | 2020 | 328 | 0.140 |
Why?
| | Colon | 1 | 2021 | 309 | 0.140 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 638 | 0.140 |
Why?
| | Bayes Theorem | 2 | 2017 | 420 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2864 | 0.130 |
Why?
| | Workflow | 1 | 2019 | 183 | 0.130 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2019 | 364 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2025 | 2046 | 0.130 |
Why?
| | Case-Control Studies | 1 | 2025 | 3623 | 0.130 |
Why?
| | Gene Expression Regulation | 2 | 2023 | 2597 | 0.120 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 418 | 0.120 |
Why?
| | Monte Carlo Method | 1 | 2017 | 147 | 0.120 |
Why?
| | Markov Chains | 1 | 2017 | 132 | 0.120 |
Why?
| | Monocytes | 1 | 2019 | 539 | 0.120 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 734 | 0.120 |
Why?
| | Neutrophils | 1 | 2021 | 1124 | 0.110 |
Why?
| | Animals | 11 | 2026 | 38030 | 0.110 |
Why?
| | Rheumatoid Factor | 2 | 2026 | 178 | 0.100 |
Why?
| | Male | 10 | 2026 | 72842 | 0.100 |
Why?
| | Mice | 7 | 2025 | 18329 | 0.100 |
Why?
| | Middle Aged | 6 | 2026 | 36215 | 0.100 |
Why?
| | Plasma Cells | 2 | 2024 | 79 | 0.090 |
Why?
| | Autoimmunity | 1 | 2019 | 933 | 0.090 |
Why?
| | Female | 10 | 2026 | 78844 | 0.090 |
Why?
| | Adult | 6 | 2025 | 40777 | 0.090 |
Why?
| | Lung | 2 | 2024 | 4106 | 0.090 |
Why?
| | Kidney | 1 | 2019 | 1497 | 0.080 |
Why?
| | Complement Fixation Tests | 1 | 2001 | 5 | 0.080 |
Why?
| | Plants, Medicinal | 1 | 2001 | 23 | 0.080 |
Why?
| | Interferons | 2 | 2024 | 186 | 0.080 |
Why?
| | Biomarkers | 2 | 2019 | 4295 | 0.080 |
Why?
| | Polysaccharides | 1 | 2001 | 86 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2025 | 679 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1217 | 0.080 |
Why?
| | Immunotherapy | 2 | 2024 | 666 | 0.070 |
Why?
| | Aged | 2 | 2025 | 26153 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5904 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2025 | 4148 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2026 | 2507 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2024 | 3124 | 0.060 |
Why?
| | Hyperplasia | 1 | 2026 | 177 | 0.060 |
Why?
| | Complement C3-C5 Convertases | 1 | 2025 | 21 | 0.060 |
Why?
| | Complement C4 | 1 | 2025 | 26 | 0.050 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 10 | 0.050 |
Why?
| | Interferon Regulatory Factors | 1 | 2025 | 44 | 0.050 |
Why?
| | Complement C3b | 1 | 2025 | 29 | 0.050 |
Why?
| | Complement Membrane Attack Complex | 1 | 2025 | 38 | 0.050 |
Why?
| | Complement C5a | 1 | 2025 | 54 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 56 | 0.050 |
Why?
| | Peptides, Cyclic | 1 | 2026 | 273 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2024 | 77 | 0.050 |
Why?
| | Oncostatin M | 1 | 2023 | 6 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 79 | 0.050 |
Why?
| | Mutation | 1 | 2015 | 4075 | 0.050 |
Why?
| | Arthritis | 1 | 2024 | 96 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2024 | 128 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2024 | 177 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 106 | 0.050 |
Why?
| | High-Throughput Screening Assays | 1 | 2025 | 176 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2024 | 167 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 317 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 233 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5983 | 0.040 |
Why?
| | Antigen-Antibody Complex | 1 | 2021 | 69 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2021 | 45 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2020 | 37 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 207 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2021 | 119 | 0.040 |
Why?
| | Endocytosis | 1 | 2021 | 168 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2020 | 67 | 0.040 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 395 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1003 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 207 | 0.040 |
Why?
| | Patient Acuity | 1 | 2020 | 48 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2024 | 364 | 0.040 |
Why?
| | Bone Marrow | 1 | 2021 | 306 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2019 | 115 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 118 | 0.040 |
Why?
| | Cell Shape | 1 | 2019 | 56 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2019 | 105 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2021 | 503 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 611 | 0.030 |
Why?
| | Pain | 1 | 2024 | 789 | 0.030 |
Why?
| | Joints | 1 | 2019 | 106 | 0.030 |
Why?
| | Cell Polarity | 1 | 2019 | 137 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2019 | 147 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2021 | 499 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1454 | 0.030 |
Why?
| | Lymphocytes | 1 | 2019 | 376 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 741 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2953 | 0.030 |
Why?
| | Cell Movement | 1 | 2021 | 959 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1509 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2170 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1082 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2015 | 52 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 362 | 0.030 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2015 | 89 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2019 | 1131 | 0.020 |
Why?
| | Alleles | 1 | 2015 | 894 | 0.020 |
Why?
| | Chromatography, DEAE-Cellulose | 1 | 2001 | 10 | 0.020 |
Why?
| | Mali | 1 | 2001 | 4 | 0.020 |
Why?
| | Monosaccharides | 1 | 2001 | 13 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10885 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2001 | 106 | 0.020 |
Why?
| | Plant Roots | 1 | 2001 | 37 | 0.020 |
Why?
| | Carbohydrates | 1 | 2001 | 66 | 0.020 |
Why?
| | Molecular Weight | 1 | 2001 | 312 | 0.020 |
Why?
| | Hydrolysis | 1 | 2001 | 197 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1048 | 0.020 |
Why?
| | Sheep | 1 | 2001 | 876 | 0.020 |
Why?
| | Wound Healing | 1 | 2001 | 355 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6066 | 0.020 |
Why?
| | Amino Acids | 1 | 2001 | 519 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2382 | 0.010 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|